AFT Pharmaceuticals (ASX:AFP) EPS (Basic) : A$0.10 (TTM As of Sep. 2023)

View and export this data going back to 2015. Start your Free Trial

What is AFT Pharmaceuticals EPS (Basic)?

AFT Pharmaceuticals's basic earnings per share (Basic EPS) for the six months ended in Sep. 2023 was A$0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2023 was A$0.10.

AFT Pharmaceuticals's EPS (Diluted) for the six months ended in Sep. 2023 was A$0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was A$0.10.

AFT Pharmaceuticals's EPS without NRI for the six months ended in Sep. 2023 was A$0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2023 was 0.10.

During the past 12 months, AFT Pharmaceuticals's average EPS without NRIGrowth Rate was -37.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was -8.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, AFT Pharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 62.70% per year. The lowest was -8.40% per year. And the median was 27.15% per year.

AFT Pharmaceuticals EPS (Basic) Historical Data

The historical data trend for AFT Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals EPS (Basic) Chart

AFT Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EPS (Basic)

Get a 7-Day Free Trial

-0.02

0.13

0.07

0.18

0.09

AFT Pharmaceuticals Semi-Annual Data
	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EPS (Basic)	Get a 7-Day Free Trial											0.04	0.14	0.01	0.08	0.02

AFT Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

AFT Pharmaceuticals's Basic EPS for the fiscal year that ended in Mar. 2023 is calculated as

Basic EPS (A: Mar. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(9.907	-	0)	/	104.849
	=	0.09

AFT Pharmaceuticals's Basic EPS for the quarter that ended in Sep. 2023 is calculated as

Basic EPS (Q: Sep. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(1.676	-	0)	/	104.866
	=	0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.10

AFT Pharmaceuticals (ASX:AFP) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

AFT Pharmaceuticals EPS (Basic) Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

AFT Pharmaceuticals (ASX:AFP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (ASX:AFP) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

AFT:New Zealand

Address

129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622

Website

https://www.aftpharm.com

AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.

AFT Pharmaceuticals (ASX:AFP) Headlines

No Headlines